StockData
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Cardiol Therapeutics Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.10+0.00 (0.00%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Cardiol Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Cardiol Therapeutics filed with the SEC